Financial Daily from THE HINDU group of publications
Friday, May 21, 2004

Cross Currency

Group Sites

Corporate - Announcements

Orchid's diabetic drug clears Phase I trials in Europe

Our Bureau

Chennai , May 20

ORCHID Chemicals & Pharmaceuticals today announced that Bexel Pharmaceutical's (its drug discovery associate) anti-diabetic molecule had cleared Phase I (b) of human trials in Europe.

The company's press release said it aims to out-license the molecule after it completes Phase 2a.

This phase would be finished by July 2004.

The molecule would also be showcased in a June 2004 meeting of the American Diabetes Association.

More Stories on : Announcements | Pharmaceuticals | Regulatory Bodies & Rulings

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
USFDA approves Granules India facility

Orchid's diabetic drug clears Phase I trials in Europe
Dr Batra's to open more clinics
Ucal Fuel drops plan to acquire Escorts Auto Components
Apollo Tyres may hike prices next month
Electrolux Kelvinator may not declare itself sick — Hopes for a turnaround soon
Tata Motors plans capacity expansion — 'Cost cutting exercise to continue this year'
UB mulls pref shares on rights basis
Atlas Products restrained from using SALTA trademark
ICAI recruiting accountants for GE India
Advance Valves sets up joint venture co in UAE
Tata Steel: Cost-trimming boosts profits
Tata Motors: An exceptional fourth quarter performance
Samsonite, VIP among HPL's clients

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line